Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice (Q47989124)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 May 2012

Language	Label	Description	Also known as
English	Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice	scientific article published on 17 May 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

author name string

Mao Horio

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Yuko Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Kenji Hashimoto

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

publication date

17 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Fundamental and Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

27

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

483-488

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Neurocognitive impairment across the lifespan in schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

The Glutamatergic Dysfunction Hypothesis for Schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Metabotropic glutamate receptors in the basal ganglia motor circuit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Recent patents on positive allosteric modulators of the metabotropic glutamate 5 receptor as a potential treatment for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activiti

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Role of Protein Kinase C Phosphorylation in Rapid Desensitization of Metabotropic Glutamate Receptor 5

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Identifiers

10.1111/J.1472-8206.2012.01045.X

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47989124&oldid=2180700115"